"119866" appears in Snohomish County PDS Online Records as a permit number for a closed complaint investigation (Permit 23 119866 CT ).
This is the Investigational New Drug (IND) number for , an interleukin-13 receptor antagonist developed by Dermira Inc. (and later Eli Lilly) for treating moderate-to-severe atopic dermatitis. 119866
This refers to the published by the United Nations High Commissioner for Refugees (UNHCR) in October 2025. "119866" appears in Snohomish County PDS Online Records